Product NDC: | 0093-4136 |
Proprietary Name: | Cefdinir |
Non Proprietary Name: | Cefdinir |
Active Ingredient(s): | 125 mg/5mL & nbsp; Cefdinir |
Administration Route(s): | ORAL |
Dosage Form(s): | POWDER, FOR SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0093-4136 |
Labeler Name: | Teva Pharmaceuticals USA Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065332 |
Marketing Category: | ANDA |
Start Marketing Date: | 20070508 |
Package NDC: | 0093-4136-73 |
Package Description: | 100 mL in 1 BOTTLE (0093-4136-73) |
NDC Code | 0093-4136-73 |
Proprietary Name | Cefdinir |
Package Description | 100 mL in 1 BOTTLE (0093-4136-73) |
Product NDC | 0093-4136 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Cefdinir |
Dosage Form Name | POWDER, FOR SUSPENSION |
Route Name | ORAL |
Start Marketing Date | 20070508 |
Marketing Category Name | ANDA |
Labeler Name | Teva Pharmaceuticals USA Inc |
Substance Name | CEFDINIR MONOHYDRATE |
Strength Number | 125 |
Strength Unit | mg/5mL |
Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |